Andrea Gabrio

Linear mixed models to handle missing at random data in trial‐based economic evaluations

Andrea Gabrio, Catrin Plumpton, Sube Banerjee et al. · Health Economics · 2022 · 122 citations · Full text

Pharmacy, Biostatistics, Pharmacoeconomics +16

Effects of gender-transformative relationships and sexuality education to reduce adolescent pregnancy (the JACK trial): a cluster-randomised trial

Maria Lohan, Aoibheann Brennan‐Wilson, Rachael Hunter et al. · The Lancet Public Health · 2022 · 34 citations · Full text

Medicine, Health Education, Preventive Medicine +17

Early extracorporeal CPR for refractory out-of-hospital cardiac arrest – A pre-planned per-protocol analysis of the INCEPTION-trial

Johannes F.H. Ubben, Martje M. Suverein, Thijs Delnoij et al. · Resuscitation · 2023 · 21 citations · Full text

Medicine, Cardiology, Emergency Medicine +13

Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data

Caroline S. Clarke, Rachael Hunter, Andrea Gabrio et al. · PLoS ONE · 2022 · 13 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Cost and Utility Estimates per Modified Rankin Scale Score up to 2 Years Post Stroke: Data to Inform Economic Evaluations From a Societal Perspective

Florentina M.E. Pinckaers, Janneke P.C. Grutters, Ilse Huijberts et al. · Value in Health · 2024 · 13 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-utility Analysis +16